0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Rabies Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-12F9112
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Rabies Vaccine Market Outlook 2022
BUY CHAPTERS

Global Human Rabies Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-12F9112
Report
August 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Rabies Vaccine Sales Market Size

The global Human Rabies Vaccine market size was US$ 1148 million in 2024 and is forecast to a readjusted size of US$ 1535 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.

Human Rabies Vaccine Sales Market

Human Rabies Vaccine Sales Market

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Human Rabies Vaccine market competitiveness, regional economic performance, and supply chain configurations.
Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
The increasing awareness of rabies prevention and the rising number of reported cases of animal bites, particularly in developing countries, are key drivers of the human rabies vaccine market. Government-led vaccination programs, international health initiatives, and educational campaigns have significantly boosted demand for pre- and post-exposure prophylaxis, including human rabies vaccines. Moreover, improvements in vaccine technology, such as the development of safer and more effective vaccines, are also contributing to the growth of the market.
One major challenge in the human rabies vaccine market is the uneven access to vaccines, especially in regions where rabies is endemic. High costs, cold chain requirements for storage, and distribution challenges in rural or underdeveloped areas make it difficult for healthcare providers to ensure timely vaccination. Additionally, a lack of healthcare infrastructure and trained personnel to administer the vaccine can hinder its effectiveness in regions most affected by rabies, limiting the overall impact of vaccination efforts.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share. Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The global Human Rabies Vaccine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation

Scope of Human Rabies Vaccine Sales Market Report

Report Metric Details
Report Name Human Rabies Vaccine Sales Market
Forecasted market size in 2031 US$ 1535 million
CAGR 4.3%
Forecasted years 2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)
  • Vero Cell
  • BHK
  • Chick Embryo Cell
  • Human Diploid Cells
  • Others
By Application: (Core Demand Driver vs Emerging Opportunity)
  • Pre-Exposure Vaccine
  • Post-Exposure Vaccine
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company: Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
  • Chapter 2: Quantitative analysis of Human Rabies Vaccine market size and growth potential at global, regional, and country levels.
  • Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
  • Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., BHK in China).
  • Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Post-Exposure Vaccine in India).
  • Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
  • Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
  • Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 9: Actionable conclusions and strategic recommendations.
  • Why This Report?
  • This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
  • - Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
  • - Product Portfolio Optimization: Align offerings with regional preferences (e.g., Vero Cell dominance in Europe vs. BHK demand in MEA).
  • - Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Human Rabies Vaccine Sales Market size in 2031?

Ans: The Human Rabies Vaccine Sales Market size in 2031 will be US$ 1535 million.

What is the Human Rabies Vaccine Sales Market share by region?

Ans: Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

Who are the main players in the Human Rabies Vaccine Sales Market report?

Ans: The main players in the Human Rabies Vaccine Sales Market are Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, KANGH, Prcmise, Henan Grand Biopharma, Zhuoyi Biological, ZhongKe Biopharm, Ningbo Rongan Biological, Indian Immunologicals

What are the Application segmentation covered in the Human Rabies Vaccine Sales Market report?

Ans: The Applications covered in the Human Rabies Vaccine Sales Market report are Pre-Exposure Vaccine, Post-Exposure Vaccine

What are the Type segmentation covered in the Human Rabies Vaccine Sales Market report?

Ans: The Types covered in the Human Rabies Vaccine Sales Market report are Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, Others

Recommended Reports

Human Vaccine Markets

Animal Vaccine Markets

Viral and Flu Vaccines

1 Market Overview
1.1 Human Rabies Vaccine Product Scope
1.2 Human Rabies Vaccine by Type
1.2.1 Global Human Rabies Vaccine Sales by Type (2020 & 2024 & 2031)
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Human Rabies Vaccine by Application
1.3.1 Global Human Rabies Vaccine Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pre-Exposure Vaccine
1.3.3 Post-Exposure Vaccine
1.4 Global Human Rabies Vaccine Market Estimates and Forecasts (2020-2031)
1.4.1 Global Human Rabies Vaccine Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Human Rabies Vaccine Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Human Rabies Vaccine Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Human Rabies Vaccine Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Human Rabies Vaccine Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Human Rabies Vaccine Sales Market Share by Region (2020-2025)
2.2.2 Global Human Rabies Vaccine Revenue Market Share by Region (2020-2025)
2.3 Global Human Rabies Vaccine Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Human Rabies Vaccine Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Human Rabies Vaccine Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Human Rabies Vaccine Market Size and Prospective (2020-2031)
2.4.2 Europe Human Rabies Vaccine Market Size and Prospective (2020-2031)
2.4.3 China Human Rabies Vaccine Market Size and Prospective (2020-2031)
2.4.4 India Human Rabies Vaccine Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Human Rabies Vaccine Historic Market Review by Type (2020-2025)
3.1.1 Global Human Rabies Vaccine Sales by Type (2020-2025)
3.1.2 Global Human Rabies Vaccine Revenue by Type (2020-2025)
3.1.3 Global Human Rabies Vaccine Price by Type (2020-2025)
3.2 Global Human Rabies Vaccine Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Human Rabies Vaccine Sales Forecast by Type (2026-2031)
3.2.2 Global Human Rabies Vaccine Revenue Forecast by Type (2026-2031)
3.2.3 Global Human Rabies Vaccine Price Forecast by Type (2026-2031)
3.3 Different Types Human Rabies Vaccine Representative Players
4 Global Market Size by Application
4.1 Global Human Rabies Vaccine Historic Market Review by Application (2020-2025)
4.1.1 Global Human Rabies Vaccine Sales by Application (2020-2025)
4.1.2 Global Human Rabies Vaccine Revenue by Application (2020-2025)
4.1.3 Global Human Rabies Vaccine Price by Application (2020-2025)
4.2 Global Human Rabies Vaccine Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Human Rabies Vaccine Sales Forecast by Application (2026-2031)
4.2.2 Global Human Rabies Vaccine Revenue Forecast by Application (2026-2031)
4.2.3 Global Human Rabies Vaccine Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Human Rabies Vaccine Application
5 Competition Landscape by Players
5.1 Global Human Rabies Vaccine Sales by Players (2020-2025)
5.2 Global Top Human Rabies Vaccine Players by Revenue (2020-2025)
5.3 Global Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2024)
5.4 Global Human Rabies Vaccine Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Human Rabies Vaccine, Product Type & Application
5.7 Global Key Manufacturers of Human Rabies Vaccine, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Human Rabies Vaccine Sales by Company
6.1.1.1 North America Human Rabies Vaccine Sales by Company (2020-2025)
6.1.1.2 North America Human Rabies Vaccine Revenue by Company (2020-2025)
6.1.2 North America Human Rabies Vaccine Sales Breakdown by Type (2020-2025)
6.1.3 North America Human Rabies Vaccine Sales Breakdown by Application (2020-2025)
6.1.4 North America Human Rabies Vaccine Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Human Rabies Vaccine Sales by Company
6.2.1.1 Europe Human Rabies Vaccine Sales by Company (2020-2025)
6.2.1.2 Europe Human Rabies Vaccine Revenue by Company (2020-2025)
6.2.2 Europe Human Rabies Vaccine Sales Breakdown by Type (2020-2025)
6.2.3 Europe Human Rabies Vaccine Sales Breakdown by Application (2020-2025)
6.2.4 Europe Human Rabies Vaccine Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Human Rabies Vaccine Sales by Company
6.3.1.1 China Human Rabies Vaccine Sales by Company (2020-2025)
6.3.1.2 China Human Rabies Vaccine Revenue by Company (2020-2025)
6.3.2 China Human Rabies Vaccine Sales Breakdown by Type (2020-2025)
6.3.3 China Human Rabies Vaccine Sales Breakdown by Application (2020-2025)
6.3.4 China Human Rabies Vaccine Major Customer
6.3.5 China Market Trend and Opportunities
6.4 India Market: Players, Segments, Downstream and Major Customers
6.4.1 India Human Rabies Vaccine Sales by Company
6.4.1.1 India Human Rabies Vaccine Sales by Company (2020-2025)
6.4.1.2 India Human Rabies Vaccine Revenue by Company (2020-2025)
6.4.2 India Human Rabies Vaccine Sales Breakdown by Type (2020-2025)
6.4.3 India Human Rabies Vaccine Sales Breakdown by Application (2020-2025)
6.4.4 India Human Rabies Vaccine Major Customer
6.4.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Bharat Biotech
7.1.1 Bharat Biotech Company Information
7.1.2 Bharat Biotech Business Overview
7.1.3 Bharat Biotech Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Bharat Biotech Human Rabies Vaccine Products Offered
7.1.5 Bharat Biotech Recent Development
7.2 Bavarian Nordic
7.2.1 Bavarian Nordic Company Information
7.2.2 Bavarian Nordic Business Overview
7.2.3 Bavarian Nordic Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Bavarian Nordic Human Rabies Vaccine Products Offered
7.2.5 Bavarian Nordic Recent Development
7.3 Sanofi-Pasteur
7.3.1 Sanofi-Pasteur Company Information
7.3.2 Sanofi-Pasteur Business Overview
7.3.3 Sanofi-Pasteur Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Sanofi-Pasteur Human Rabies Vaccine Products Offered
7.3.5 Sanofi-Pasteur Recent Development
7.4 Chengda Bio
7.4.1 Chengda Bio Company Information
7.4.2 Chengda Bio Business Overview
7.4.3 Chengda Bio Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Chengda Bio Human Rabies Vaccine Products Offered
7.4.5 Chengda Bio Recent Development
7.5 KANGH
7.5.1 KANGH Company Information
7.5.2 KANGH Business Overview
7.5.3 KANGH Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.5.4 KANGH Human Rabies Vaccine Products Offered
7.5.5 KANGH Recent Development
7.6 Prcmise
7.6.1 Prcmise Company Information
7.6.2 Prcmise Business Overview
7.6.3 Prcmise Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Prcmise Human Rabies Vaccine Products Offered
7.6.5 Prcmise Recent Development
7.7 Henan Grand Biopharma
7.7.1 Henan Grand Biopharma Company Information
7.7.2 Henan Grand Biopharma Business Overview
7.7.3 Henan Grand Biopharma Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Henan Grand Biopharma Human Rabies Vaccine Products Offered
7.7.5 Henan Grand Biopharma Recent Development
7.8 Zhuoyi Biological
7.8.1 Zhuoyi Biological Company Information
7.8.2 Zhuoyi Biological Business Overview
7.8.3 Zhuoyi Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Zhuoyi Biological Human Rabies Vaccine Products Offered
7.8.5 Zhuoyi Biological Recent Development
7.9 ZhongKe Biopharm
7.9.1 ZhongKe Biopharm Company Information
7.9.2 ZhongKe Biopharm Business Overview
7.9.3 ZhongKe Biopharm Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.9.4 ZhongKe Biopharm Human Rabies Vaccine Products Offered
7.9.5 ZhongKe Biopharm Recent Development
7.10 Ningbo Rongan Biological
7.10.1 Ningbo Rongan Biological Company Information
7.10.2 Ningbo Rongan Biological Business Overview
7.10.3 Ningbo Rongan Biological Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Ningbo Rongan Biological Human Rabies Vaccine Products Offered
7.10.5 Ningbo Rongan Biological Recent Development
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Company Information
7.11.2 Indian Immunologicals Business Overview
7.11.3 Indian Immunologicals Human Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Indian Immunologicals Human Rabies Vaccine Products Offered
7.11.5 Indian Immunologicals Recent Development
8 Human Rabies Vaccine Manufacturing Cost Analysis
8.1 Human Rabies Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Human Rabies Vaccine
8.4 Human Rabies Vaccine Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Human Rabies Vaccine Distributors List
9.3 Human Rabies Vaccine Customers
10 Human Rabies Vaccine Market Dynamics
10.1 Human Rabies Vaccine Industry Trends
10.2 Human Rabies Vaccine Market Drivers
10.3 Human Rabies Vaccine Market Challenges
10.4 Human Rabies Vaccine Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
 Table 1. Global Human Rabies Vaccine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Human Rabies Vaccine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Human Rabies Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Human Rabies Vaccine Sales (K Units) by Region (2020-2025)
 Table 5. Global Human Rabies Vaccine Sales Market Share by Region (2020-2025)
 Table 6. Global Human Rabies Vaccine Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Human Rabies Vaccine Revenue Share by Region (2020-2025)
 Table 8. Global Human Rabies Vaccine Sales (K Units) Forecast by Region (2026-2031)
 Table 9. Global Human Rabies Vaccine Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Human Rabies Vaccine Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Human Rabies Vaccine Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Human Rabies Vaccine Sales by Type (K Units) & (2020-2025)
 Table 13. Global Human Rabies Vaccine Sales Share by Type (2020-2025)
 Table 14. Global Human Rabies Vaccine Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Human Rabies Vaccine Price by Type (US$/Unit) & (2020-2025)
 Table 16. Global Human Rabies Vaccine Sales by Type (K Units) & (2026-2031)
 Table 17. Global Human Rabies Vaccine Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Human Rabies Vaccine Price by Type (US$/Unit) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Human Rabies Vaccine Sales by Application (K Units) & (2020-2025)
 Table 21. Global Human Rabies Vaccine Sales Share by Application (2020-2025)
 Table 22. Global Human Rabies Vaccine Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Human Rabies Vaccine Price by Application (US$/Unit) & (2020-2025)
 Table 24. Global Human Rabies Vaccine Sales by Application (K Units) & (2026-2031)
 Table 25. Global Human Rabies Vaccine Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Human Rabies Vaccine Price by Application (US$/Unit) & (2026-2031)
 Table 27. New Sources of Growth in Human Rabies Vaccine Application
 Table 28. Global Human Rabies Vaccine Sales by Company (K Units) & (2020-2025)
 Table 29. Global Human Rabies Vaccine Sales Share by Company (2020-2025)
 Table 30. Global Human Rabies Vaccine Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Human Rabies Vaccine Revenue Share by Company (2020-2025)
 Table 32. Global Human Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2024)
 Table 33. Global Market Human Rabies Vaccine Average Price by Company (US$/Unit) & (2020-2025)
 Table 34. Global Key Manufacturers of Human Rabies Vaccine, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Human Rabies Vaccine, Product Type & Application
 Table 36. Global Key Manufacturers of Human Rabies Vaccine, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Human Rabies Vaccine Sales by Company (2020-2025) & (K Units)
 Table 39. North America Human Rabies Vaccine Sales Market Share by Company (2020-2025)
 Table 40. North America Human Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Human Rabies Vaccine Revenue Market Share by Company (2020-2025)
 Table 42. North America Human Rabies Vaccine Sales by Type (2020-2025) & (K Units)
 Table 43. North America Human Rabies Vaccine Sales Market Share by Type (2020-2025)
 Table 44. North America Human Rabies Vaccine Sales by Application (2020-2025) & (K Units)
 Table 45. North America Human Rabies Vaccine Sales Market Share by Application (2020-2025)
 Table 46. Europe Human Rabies Vaccine Sales by Company (2020-2025) & (K Units)
 Table 47. Europe Human Rabies Vaccine Sales Market Share by Company (2020-2025)
 Table 48. Europe Human Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Human Rabies Vaccine Revenue Market Share by Company (2020-2025)
 Table 50. Europe Human Rabies Vaccine Sales by Type (2020-2025) & (K Units)
 Table 51. Europe Human Rabies Vaccine Sales Market Share by Type (2020-2025)
 Table 52. Europe Human Rabies Vaccine Sales by Application (2020-2025) & (K Units)
 Table 53. Europe Human Rabies Vaccine Sales Market Share by Application (2020-2025)
 Table 54. China Human Rabies Vaccine Sales by Company (2020-2025) & (K Units)
 Table 55. China Human Rabies Vaccine Sales Market Share by Company (2020-2025)
 Table 56. China Human Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Human Rabies Vaccine Revenue Market Share by Company (2020-2025)
 Table 58. China Human Rabies Vaccine Sales by Type (2020-2025) & (K Units)
 Table 59. China Human Rabies Vaccine Sales Market Share by Type (2020-2025)
 Table 60. China Human Rabies Vaccine Sales by Application (2020-2025) & (K Units)
 Table 61. China Human Rabies Vaccine Sales Market Share by Application (2020-2025)
 Table 62. India Human Rabies Vaccine Sales by Company (2020-2025) & (K Units)
 Table 63. India Human Rabies Vaccine Sales Market Share by Company (2020-2025)
 Table 64. India Human Rabies Vaccine Revenue by Company (2020-2025) & (US$ Million)
 Table 65. India Human Rabies Vaccine Revenue Market Share by Company (2020-2025)
 Table 66. India Human Rabies Vaccine Sales by Type (2020-2025) & (K Units)
 Table 67. India Human Rabies Vaccine Sales Market Share by Type (2020-2025)
 Table 68. India Human Rabies Vaccine Sales by Application (2020-2025) & (K Units)
 Table 69. India Human Rabies Vaccine Sales Market Share by Application (2020-2025)
 Table 70. Bharat Biotech Company Information
 Table 71. Bharat Biotech Description and Business Overview
 Table 72. Bharat Biotech Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bharat Biotech Human Rabies Vaccine Product
 Table 74. Bharat Biotech Recent Development
 Table 75. Bavarian Nordic Company Information
 Table 76. Bavarian Nordic Description and Business Overview
 Table 77. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bavarian Nordic Human Rabies Vaccine Product
 Table 79. Bavarian Nordic Recent Development
 Table 80. Sanofi-Pasteur Company Information
 Table 81. Sanofi-Pasteur Description and Business Overview
 Table 82. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi-Pasteur Human Rabies Vaccine Product
 Table 84. Sanofi-Pasteur Recent Development
 Table 85. Chengda Bio Company Information
 Table 86. Chengda Bio Description and Business Overview
 Table 87. Chengda Bio Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Chengda Bio Human Rabies Vaccine Product
 Table 89. Chengda Bio Recent Development
 Table 90. KANGH Company Information
 Table 91. KANGH Description and Business Overview
 Table 92. KANGH Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. KANGH Human Rabies Vaccine Product
 Table 94. KANGH Recent Development
 Table 95. Prcmise Company Information
 Table 96. Prcmise Description and Business Overview
 Table 97. Prcmise Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Prcmise Human Rabies Vaccine Product
 Table 99. Prcmise Recent Development
 Table 100. Henan Grand Biopharma Company Information
 Table 101. Henan Grand Biopharma Description and Business Overview
 Table 102. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Henan Grand Biopharma Human Rabies Vaccine Product
 Table 104. Henan Grand Biopharma Recent Development
 Table 105. Zhuoyi Biological Company Information
 Table 106. Zhuoyi Biological Description and Business Overview
 Table 107. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Zhuoyi Biological Human Rabies Vaccine Product
 Table 109. Zhuoyi Biological Recent Development
 Table 110. ZhongKe Biopharm Company Information
 Table 111. ZhongKe Biopharm Description and Business Overview
 Table 112. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. ZhongKe Biopharm Human Rabies Vaccine Product
 Table 114. ZhongKe Biopharm Recent Development
 Table 115. Ningbo Rongan Biological Company Information
 Table 116. Ningbo Rongan Biological Description and Business Overview
 Table 117. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ningbo Rongan Biological Human Rabies Vaccine Product
 Table 119. Ningbo Rongan Biological Recent Development
 Table 120. Indian Immunologicals Company Information
 Table 121. Indian Immunologicals Description and Business Overview
 Table 122. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Indian Immunologicals Human Rabies Vaccine Product
 Table 124. Indian Immunologicals Recent Development
 Table 125. Production Base and Market Concentration Rate of Raw Material
 Table 126. Key Suppliers of Raw Materials
 Table 127. Human Rabies Vaccine Distributors List
 Table 128. Human Rabies Vaccine Customers List
 Table 129. Human Rabies Vaccine Market Trends
 Table 130. Human Rabies Vaccine Market Drivers
 Table 131. Human Rabies Vaccine Market Challenges
 Table 132. Human Rabies Vaccine Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Rabies Vaccine Product Picture
 Figure 2. Global Human Rabies Vaccine Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Human Rabies Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Vero Cell Product Picture
 Figure 5. BHK Product Picture
 Figure 6. Chick Embryo Cell Product Picture
 Figure 7. Human Diploid Cells Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Human Rabies Vaccine Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 10. Global Human Rabies Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 11. Pre-Exposure Vaccine Examples
 Figure 12. Post-Exposure Vaccine Examples
 Figure 13. Global Human Rabies Vaccine Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Human Rabies Vaccine Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 15. Global Human Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)
 Figure 16. Global Human Rabies Vaccine Price Trends Growth Rate (2020-2031) & (US$/Unit)
 Figure 17. Human Rabies Vaccine Report Years Considered
 Figure 18. Global Market Human Rabies Vaccine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 19. Global Human Rabies Vaccine Revenue Market Share by Region: 2020 VS 2024
 Figure 20. North America Human Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 21. North America Human Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)
 Figure 22. Europe Human Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 23. Europe Human Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)
 Figure 24. China Human Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 25. China Human Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)
 Figure 26. India Human Rabies Vaccine Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 27. India Human Rabies Vaccine Sales (K Units) Growth Rate (2020-2031)
 Figure 28. Global Human Rabies Vaccine Revenue Share by Type (2020-2025)
 Figure 29. Global Human Rabies Vaccine Sales Share by Type (2026-2031)
 Figure 30. Global Human Rabies Vaccine Revenue Share by Type (2026-2031)
 Figure 31. Global Human Rabies Vaccine Revenue Share by Application (2020-2025)
 Figure 32. Global Human Rabies Vaccine Revenue Growth Rate by Application in 2020 & 2024
 Figure 33. Global Human Rabies Vaccine Sales Share by Application (2026-2031)
 Figure 34. Global Human Rabies Vaccine Revenue Share by Application (2026-2031)
 Figure 35. Global Human Rabies Vaccine Sales Share by Company (2024)
 Figure 36. Global Human Rabies Vaccine Revenue Share by Company (2024)
 Figure 37. Global 5 Largest Human Rabies Vaccine Players Market Share by Revenue in Human Rabies Vaccine: 2020 & 2024
 Figure 38. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 39. Manufacturing Cost Structure of Human Rabies Vaccine
 Figure 40. Manufacturing Process Analysis of Human Rabies Vaccine
 Figure 41. Human Rabies Vaccine Industrial Chain
 Figure 42. Channels of Distribution (Direct Vs Distribution)
 Figure 43. Distributors Profiles
 Figure 44. Bottom-up and Top-down Approaches for This Report
 Figure 45. Data Triangulation
 Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4250

This license allows only one user to access the PDF.
Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension